Inmune Bio (INMB) FCF Margin (2021 - 2025)
Historic FCF Margin for Inmune Bio (INMB) over the last 5 years, with Q1 2025 value amounting to 13648.0%.
- Inmune Bio's FCF Margin rose 397520000.0% to 13648.0% in Q1 2025 from the same period last year, while for Sep 2025 it was 61766.0%, marking a year-over-year decrease of 4112400.0%. This contributed to the annual value of 238571.43% for FY2024, which is 2308294900.0% down from last year.
- Inmune Bio's FCF Margin amounted to 13648.0% in Q1 2025, which was up 397520000.0% from 53400.0% recorded in Q1 2024.
- In the past 5 years, Inmune Bio's FCF Margin registered a high of 3002.63% during Q1 2023, and its lowest value of 127300.0% during Q1 2021.
- Its 5-year average for FCF Margin is 25651.3%, with a median of 9916.28% in 2023.
- As far as peak fluctuations go, Inmune Bio's FCF Margin surged by 1218613500bps in 2022, and later plummeted by -503973700bps in 2024.
- Quarter analysis of 5 years shows Inmune Bio's FCF Margin stood at 6000.0% in 2021, then rose by 2bps to 5871.13% in 2022, then crashed by -108bps to 12217.86% in 2023, then plummeted by -337bps to 53400.0% in 2024, then soared by 74bps to 13648.0% in 2025.
- Its FCF Margin stands at 13648.0% for Q1 2025, versus 53400.0% for Q1 2024 and 12217.86% for Q4 2023.